Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Immunogen
Company Monitoring Page for Immunogen
latest headlines for company on cafepharma
Emergence of ADCs as the “hot, new technology”
Pharmaphorum
Thu, 04/25/24 - 11:39 am
Tags:
antibody-drug conjugate
,
Immunogen
,
AbbVie
,
Seagen
,
Pfizer
,
cancer
,
M&A
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology
,
M&A
,
AbbVie
,
Immunogen
,
Bristol Myers Squibb
,
Mirati Therapeutics
,
RayzeBio
,
Novartis
,
MorphoSys
,
AstraZeneca
,
Fusion Pharmaceuticals
,
JNJ
,
Ambrx
,
Gracell
AbbVie wraps up its $10.1B buyout of ImmunoGen well ahead of schedule
Fierce Pharma
Mon, 02/12/24 - 11:07 pm
Tags:
AbbVie
,
Immunogen
,
M&A
Inside AbbVie's $10B buyout of ImmunoGen—and the bidding war it swooped in on
Fierce Pharma
Tue, 01/2/24 - 10:11 pm
Tags:
AbbVie
,
Immunogen
,
M&A
,
antibody-drug conjugate
Sanofi’s oncology strategy suffers another blow as ADC scrapped over phase 3 lung cancer fail
Fierce Biotech
Thu, 12/21/23 - 09:40 am
Tags:
Sanofi
,
antibody-drug conjugate
,
lung cancer
,
clinical trials
,
tusamitamab ravtansine
,
Immunogen
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Medical Marketing and Media
Fri, 12/1/23 - 09:43 am
Tags:
biotech stocks
,
AbbVie
,
Immunogen
,
M&A
AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field
Fierce Pharma
Thu, 11/30/23 - 10:20 am
Tags:
AbbVie
,
M&A
,
antibody-drug conjugate
,
Immunogen
,
Elahere
,
ovarian cancer
ImmunoGen Inks Cancer ADC Partnership with ImmunoBiochem
BioSpace
Tue, 07/25/23 - 08:43 pm
Tags:
Immunogen
,
ImmunoBiochem
,
cancer
,
antibody-drug conjugate
ImmunoGen’s drug Elahere offers hope for ovarian cancer patients
Clinical Trials Arena
Wed, 05/17/23 - 10:50 pm
Tags:
Immunogen
,
Elahere
,
clinical trials
,
platinum-resistant ovarian cancer
,
ovarian cancer
ImmunoGen reports positive top-line data from ovarian cancer therapy trial
Clinical Trials Arena
Thu, 05/4/23 - 09:17 am
Tags:
Immunogen
,
clinical trial
,
ovarian cancer
,
platinum-resistant ovarian cancer
,
Elahere
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Tags:
Aldeyra Therapeutics
,
Autolus Therapeutics
,
Bavarian Nordic
,
BioXcel Therapeutics
,
Disc Medicine
,
Editas Medicine
,
Immunogen
,
Lantheus
,
Mersana Therapeutics
,
NGM Biopharmaceuticals
,
Omeros
,
Roche
,
Sutro BioPharma
,
uniQure
,
Valneva
,
Viking Therapeutics
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Wed, 03/1/23 - 09:56 am
Tags:
Vertex Pharmaceuticals
,
Immunogen
,
gen editing
,
antibody-drug conjugate
,
exa-cel
Biotech’s key upcoming clinical results
EP Vantage
Tue, 12/20/22 - 10:27 am
Tags:
clinical trials
,
Acadia Pharmaceuticals
,
Argenx
,
Arrowhead Pharmaceuticals
,
Biomarin
,
BioNTech
,
Daiichi Sankyo
,
Day One
,
EQRx
,
Fate Therapeutics
,
FibroGen
,
Gilead Sciences
,
Idorsia
,
Immunogen
,
Intellia Therapeutics
,
Karuna Therapeutics
,
Moderna Therapeutics
,
Regeneron
,
Roche
,
Travere Therapeutics
,
Vaxcyte
FDA Action Alert: Spectrum, ImmunoGen, Scynexis and Y-mAbs
BioSpace
Mon, 11/21/22 - 10:06 am
Tags:
FDA
,
Spectrum Pharmaceuticals
,
poziotinib
,
Immunogen
,
mirevtuximab soravtansine
,
Scynexis
,
Brexafemme
,
Y-mAbs
,
Omblastys
FDA bestows accelerated approval on ImmunoGen's ovarian cancer drug, with confirmatory answer coming soon
Endpoints
Tue, 11/15/22 - 10:41 am
Tags:
Immunogen
,
FDA
,
ovarian cancer
,
mirvetuximab soravtansine
ImmunoGen commercial chief to withdraw before drug launch
Medical Marketing and Media
Fri, 11/4/22 - 10:27 am
Tags:
Immunogen
,
mirvetuximab soravtansine
,
ovarian cancer
After chat with FDA, ImmunoGen delays pivotal top-line data on blood cancer ADC to 2024
Fierce Biotech
Wed, 08/31/22 - 10:31 am
Tags:
Immunogen
,
antibody drug conjugate
,
pivekimab sunirine
,
blood cancer
ADC Space Continues to Thrive with Four More Companies Linking Up
BioSpace
Thu, 06/16/22 - 10:30 am
Tags:
antibody-drug conjugate
,
Exelixis
,
Bioinvent
,
Oxford BioTherapeutics
,
Immunogen
Amid Waves of Biotech Layoffs, ADC Developers like ImmunoGen are Thriving
BioSpace
Mon, 05/9/22 - 09:58 am
Tags:
layoffs
,
antibody-drug conjugate
,
Seagen
,
Immunogen
ImmunoGen Ovarian Cancer Drug Reaches BLA Milestone
BioSpace
Tue, 03/29/22 - 11:37 pm
Tags:
Immunogen
,
ovarian cancer
,
FDA
,
mirvetuximab soravtansine
Pages
1
2
3
4
5
6
7
8
9
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.